DK164161C - Kondenserede benzazepiner, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af saadanne praeparater samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater - Google Patents

Kondenserede benzazepiner, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af saadanne praeparater samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater

Info

Publication number
DK164161C
DK164161C DK479087A DK479087A DK164161C DK 164161 C DK164161 C DK 164161C DK 479087 A DK479087 A DK 479087A DK 479087 A DK479087 A DK 479087A DK 164161 C DK164161 C DK 164161C
Authority
DK
Denmark
Prior art keywords
preparations
procedures
benzazepines
condensed
preparing
Prior art date
Application number
DK479087A
Other languages
English (en)
Other versions
DK479087A (da
DK479087D0 (da
DK164161B (da
Inventor
Joel Gilbert Berger
Wei Kong Chang
Elijah Herman Gold
John Welch Clader
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DK479087A publication Critical patent/DK479087A/da
Publication of DK479087D0 publication Critical patent/DK479087D0/da
Publication of DK164161B publication Critical patent/DK164161B/da
Application granted granted Critical
Publication of DK164161C publication Critical patent/DK164161C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK479087A 1986-01-16 1987-09-14 Kondenserede benzazepiner, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af saadanne praeparater samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater DK164161C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82047186A 1986-01-16 1986-01-16
US82047186 1986-01-16
PCT/US1987/000042 WO1987004430A2 (en) 1986-01-16 1987-01-14 Fused benzazepines
US8700042 1987-01-14

Publications (4)

Publication Number Publication Date
DK479087A DK479087A (da) 1987-09-14
DK479087D0 DK479087D0 (da) 1987-09-14
DK164161B DK164161B (da) 1992-05-18
DK164161C true DK164161C (da) 1992-10-26

Family

ID=25230864

Family Applications (1)

Application Number Title Priority Date Filing Date
DK479087A DK164161C (da) 1986-01-16 1987-09-14 Kondenserede benzazepiner, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelserne, fremgangsmaade til fremstilling af saadanne praeparater samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater

Country Status (19)

Country Link
EP (2) EP0254737B1 (da)
JP (1) JPH0681745B2 (da)
KR (1) KR900007781B1 (da)
AU (1) AU588080B2 (da)
CA (1) CA1333485C (da)
CS (1) CS414091A3 (da)
DK (1) DK164161C (da)
ES (1) ES2031834T3 (da)
FI (1) FI83512C (da)
GR (1) GR3000994T3 (da)
HU (1) HU199805B (da)
IE (1) IE59651B1 (da)
IL (2) IL81268A0 (da)
NZ (1) NZ218953A (da)
OA (1) OA08660A (da)
PT (1) PT84109B (da)
SG (1) SG128692G (da)
WO (1) WO1987004430A2 (da)
ZA (1) ZA87291B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4973586A (en) 1986-01-16 1990-11-27 Schering Corporation Fused benzazepines, compositions of, and medical use thereof
WO1989000561A1 (en) * 1987-07-15 1989-01-26 Schering Corporation Fused benzazepines
DK325188D0 (da) * 1988-06-15 1988-06-15 Novo Industri As Hidtil ukendte benzazepinderivater
EP0451145A1 (en) * 1988-07-29 1991-10-16 Schering Corporation A PROCESS FOR THE ENANTIOSPECIFIC SYNTHESIS OF INTERMEDIATES FOR HEXAHYDRO-BENZO d]NAPHTHO 2,1-b]AZEPINES
US5091526A (en) * 1988-07-29 1992-02-25 Schering Corporation Process for the enantiospecific synthesis of intermediates for hexahydro-benzo[d]-naphtho[2,1-b]azepines
US5104814A (en) * 1988-11-22 1992-04-14 Schering Corporation Assay kit and methods for neuroleptic drugs
FR2642065B1 (fr) * 1989-01-24 1991-05-24 Lipha Derives d'acides benzocycloalcenyl dihydroxy alcanoiques, procede de preparation et medicaments les contenant
EP0513174B1 (en) * 1990-02-02 1995-08-16 Schering Corporation 4,5-cycloalkano-3-benzazepin-7-ol-derivatives and their use
US5461147A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5461148A (en) * 1993-09-27 1995-10-24 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
US5463051A (en) * 1993-09-27 1995-10-31 Schering Corporation Process for preparing benzazepine intermediates for the synthesis of D1 antagonists
AR027687A1 (es) * 2000-03-22 2003-04-09 Yakult Honsha Kk Procedimiento para preparar camptotecina
IL163666A0 (en) 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Active agent delivery systems and methods for protecting and administering active agents
JP4555685B2 (ja) * 2002-08-29 2010-10-06 シェーリング コーポレイション 肥満およびｃｎｓ障害の処置のための選択的ｄ１／ｄ５レセプターアンタゴニスト
WO2005035504A2 (en) * 2003-05-22 2005-04-21 Schering Corporation 5-h -benzo [d] naphth [2, 1-b] azepine derivative as selective d1/d5 receptor antagonists for the treatment of obesity and cns disorders
JP5513378B2 (ja) 2007-06-15 2014-06-04 ユニバーシティ オブ フロリダ リサーチ ファウンデーション，インコーポレイテッド 治療化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3393192A (en) * 1965-04-26 1968-07-16 Schering Corp Novel benzazepines
GB1118688A (en) 1967-02-17 1968-07-03 Scherico Ltd Novel benzazepines and process for making same
CH481110A (de) * 1967-02-17 1969-11-15 Geigy Ag J R Verfahren zur Herstellung von 1,2,4,5-Tetrahydro-3-azepinen
US3609138A (en) 1967-12-22 1971-09-28 Ciba Geigy Corp 1-aryl-3-benzazepines
FR2137627A1 (da) * 1971-05-10 1972-12-29 Hoffmann La Roche
US3939165A (en) * 1974-11-14 1976-02-17 Morton-Norwich Products, Inc. 5,6,6A,6B,7,8-Hexahydrobenz[a]phenanthridine hydrochloride
US4011319A (en) 1975-07-02 1977-03-08 Smithkline Corporation Pharmaceutical compositions and methods involving benzazepine derivatives
US4284555A (en) 1979-04-27 1981-08-18 Schering Corporation 7-Chloro-8(substituted amino carbonyloxy)-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines
US4477378A (en) 1980-02-05 1984-10-16 Schering Corp. Esters of substituted 8-hydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines

Also Published As

Publication number Publication date
KR900007781B1 (ko) 1990-10-20
HUT48600A (en) 1989-06-28
ES2031834T3 (es) 1993-01-01
WO1987004430A3 (en) 1988-03-24
PT84109B (pt) 1989-07-31
FI83512B (fi) 1991-04-15
IE870112L (en) 1987-07-16
EP0254737A1 (en) 1988-02-03
JPS63502348A (ja) 1988-09-08
PT84109A (en) 1987-02-01
IL103007A (en) 1993-07-08
IE59651B1 (en) 1994-03-09
GR3000994T3 (en) 1991-12-10
AU588080B2 (en) 1989-09-07
DK479087A (da) 1987-09-14
EP0254737B1 (en) 1990-07-25
CA1333485C (en) 1994-12-13
EP0230270B1 (en) 1990-08-01
WO1987004430A2 (en) 1987-07-30
FI874006L (fi) 1987-09-15
JPH0681745B2 (ja) 1994-10-19
DK479087D0 (da) 1987-09-14
EP0230270A2 (en) 1987-07-29
SG128692G (en) 1993-03-12
IL81268A0 (en) 1987-08-31
HU199805B (en) 1990-03-28
CS414091A3 (en) 1992-05-13
FI874006A0 (fi) 1987-09-15
FI83512C (fi) 1991-07-25
EP0230270A3 (en) 1987-10-21
KR880700794A (ko) 1988-04-12
DK164161B (da) 1992-05-18
OA08660A (en) 1988-11-30
ZA87291B (en) 1987-11-25
NZ218953A (en) 1990-03-27
AU6892087A (en) 1987-08-14

Similar Documents

Publication Publication Date Title
NO871791L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende syrelabile stoffer for oral anvendelse.
DK195988A (da) Farmaceutisk praeparat indeholdende mikrokapsler
NO854194L (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater inneholdende antracyklinglykosider.
NO882075D0 (no) 9-alfa-hydroksysteroider, deres fremstilling, en fremgangsmaate for fremstilling av de tilsvarende 9(11)-dehydro-derivater samt farmasoeytiske preparater inneholdend
DK28787A (da) Thieno-1,4-diazepinforbindelser samt farmaceutiske praeparater med indhold af saadanne forbindelser
DK163991C (da) Dichloranilinderivater, fremgangsmaade til fremstilling af disse, samt farmaceutiske praeparater indeholdende derivaterne
DK153387A (da) Fremgangsmaade til fremstilling af laegemiddel-adsorbater
NO872551D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO873183L (no) Fremgangsmaate til fremstilling av reninhemmende di- og tri-peptider.
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK127588A (da) Beta-aminoethylsubstituerede phenylforbindelser, farmaceutiske praeparater indeholdende samme og fremgangsmaader til fremstilling af saadanne forbindelser
DK378187A (da) Bata-lactamforbindelse, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende forbindelsen samt mellemprodukter til anvendelse ved fremstillingen deraf
DK109887D0 (da) Farmaceutisk praeparat indeholdende antistoffer
DK531387A (da) 3-propenylcephemderivater, mellemprodukter til anvendelse ved fremstillingen heraf og praeparater indeholdende foerstnaevnte forbindelser.
DK342187D0 (da) 4-pyridin-derivater, fremgangsmaade til fremstilling af saadanne derivater samt farmaceutiske praeparater indeholdende disse
DK166088C (da) 2'-deoxy-5-fluoruridinderivater, fremgangsmaade til fremstilling deraf, anticancermidler indeholdende saadanne forbindelser og anvendelse af saadanne forbindelser til fremstilling af anticancermidler
NO874200D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK163128C (da) Pyrimidinnucleosider, fremgangsmaade til fremstilling deraf, farmaceutiske praeparater indeholdende pyrimidinnucleosiderne og anvendelse af pyrimidinnucleosiderne
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
NO873514L (no) Fremgangsmaate for fremstilling av farmasoeytisk aktive forbindelser.
DK291189D0 (da) Kondenserede diazepinoner, fremgangsmaade til fremstilling af saadanne forbindelser og laegemidler med indhold af forbindelserne
NO873423D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO875359D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
NO872233D0 (no) Fremgangsmaate for fremstilling av farmasoeytiske preparater
DK93385A (da) 3-amino-1-(4,5,6,7-tetrahydro-benzothiazolyl)-2-pyrazoliner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser

Legal Events

Date Code Title Description
PBP Patent lapsed